CD8A and neoplasm: Further support for the immunostimulatory role of IL-10 comes from studies in rodent tumour models where IL-10 administration promotes proliferation and expansion of tumor-resident cytotoxic CD8+ T cells as well as IFNγ production, thereby enhancing antitumor activity (17).